Acrongenomics Inc.
From Wikipedia, the free encyclopedia
 |
This article may require cleanup to meet Wikipedia's quality standards. Please improve this article if you can. (September 2007) |
Acrongenomics Inc. (OTCBB:AGNM) is a publicly traded company that focuses on investing in and commercializing novel technology platforms concerning the Life Sciences sector. Acrongenomics brings novel and realistic concepts to market by transforming scientific innovations into tangible, consumer-oriented applications. The company was founded in 2004 and its headquarters are located at Geneva, Switzerland.
Acrongenomics' goal is to advance the Medical Diagnostics industry and accomplish industry-leading growth by establishing our technology platform worldwide. Through innovative and advanced medical diagnostic applications, we aim to provide the most efficient and sustainable means of delivering new value to the marketplace.
Contents |
[edit] Board Of Directors
Platon Tzouvalis MSc President
Mr. Tzouvalis, 42, was appointed President of Acrongenomics, Inc. on October 5th, 2006. As a Biochemist and ex-Abbott Laboratories Associate, he is an experienced pharmaceutical industry professional. He has been a member of Acrongenomics' Scientific Advisory Board since May 2004, and member of the Board of Directors as Vice President since February 14th, 2006. His expertise lies in the areas of Quality Control, Operational Procedures as well as Pharmaceutical Product and Process Improvement. He received his B.Sc. Degree in Biochemistry from the University of Illinois in 1990 and his Master's Degree in the same field from DePaul University at Chicago in 1995. Mr. Tzouvalis' earlier career includes working as a Research Chemist in collaboration with the University of Illinois at Chicago, holding the position of Research and Development Chemist at SynQuest, Inc. and as Advanced Quality Assurance Specialist of Organic Operations and then Project Manager in Bioanalytical Quality Assurance for Abbott Laboratories. Mr. Tzouvalis has also been awarded with the Abbott Diagnostics Division Science Award of 2002 as part of the Organic Operation Remediation Team.
Ron Lizee B.Comm. CGA. CFP Chief Financial Officer
Mr. Lizee, 52, was appointed Chief Financial Officer of Acrongenomics in 2004. Mr. Lizee has over 25 years experience in the fields of tax, accounting and auditing.
Manos Topoglidis PhD Chief Technology Officer
Dr. Topoglidis, 32, was appointed to the Board of Directors and Scientific Advisory Board on February 24, 2006 as Chief Technology Officer. He received his Bachelor's of Science from King's College (University of London) in 1996, his MSc in Biochemistry from Imperial College London in 1997 and his Ph.D. in Chemistry (Biosensors and Nanomaterials) from Imperial College London in 2001. His research interests and expertise lie in the areas of Biosensors, Nanomaterials, Biotechnology and Nanotechnology. He has worked as a research fellow at the Center of Electronic Materials and Devices of Imperial College London and as manager of European and National programs at the MESL laboratory of the National Centre for Scientific Research, Demokritos in Athens. He is a member of the Electrochemical and British Biochemical Societies. Dr. Topoglidis has impressive experience leading international research teams in academia to unlock nanotechnology solutions. He ranks among the first to extensively research the use of nanoporous surfaces for biosensing applications and has written numerous original nanotechnology-related publications, which have been cited worldwide.
Dr. Evan Manolis Director
Dr. Evan Manolis received his B.S. from University of Illinois at Chicago in 1987 and his M.D. in surgery from Southern Illinois University Medical School in 1991. He received extensive postgraduate training in general surgery internship and residency from the Medical College in Ohio.Β Dr. Manolis practices plastic surgery in Chicago and Orland Park, Illinois and has been in the profession for 16 years.
[edit] Scientific Advisory Board
Professor Donal Bradley
Professor Donal Bradley is the head of the Physics Department at Imperial College London and enjoys an international reputation for his organic semiconductor research. He is the 3rd most cited scientist in the field of physical sciences. In 2005, he was awarded the prestigious Jan Rajchman Prize by the Society for Information Displays for outstanding scientific and technical research in the field of flat-panel displays. He also received the 2005 European Latsis Prize for Nano-Engineering, awarded by the European Science Foundation, for research on molecular-level control of the performance of organic semi-conducting materials and devices. This year he was a runner-up in the inaugural European Inventor of the Year Awards.
Professor Andrew de Mello
Professor Andrew de Mello is a professor of Chemical Nanosciences in the Department of Chemistry at Imperial College. He is a pioneer in the field of microfluidics. In 2002, he was awarded the SAC Silver Medal by the Royal Society of Chemistry for his contribution to the Analytical Sciences.
Dr. John de Mello
Dr. John de Mello is a senior lecturer in nanomaterials in the Department of Chemistry at Imperial College. His primary research interests include organic semiconductors, miniaturized devices for chemical and biological diagnostics, and intelligent synthesis techniques for the controlled production of nanoparticles. He serves on the Editorial Boards of Chemical Society Reviews and the Journal of Experimental Nanoscience.
Mr. Platon Tzouvalis MSc
Mr. Platon Tzouvalis MSc is an experienced pharmaceutical industry professional. He has been a member of Acrongenomics' Scientific Advisory Board since May 2004. His expertise lies in the areas of Quality Control, Operational Procedures as well as Medical Devices, Pharmaceutical Product and Process Improvement.
Dr. Manos Topoglidis
Dr. Manos Topoglidis was appointed to the Board of Directors and Scientific Advisory Board on February 23rd 2006 as Chief Technology Officer. His research interests and expertise lie in the areas of Biosensors, Nanomaterials, Biotechnology and Nanotechnology. Dr. Topoglidis has 15 scientific publications during his 8 years of research and has presented his work in 10 U.S./international conferences.
Dr. Evan Manolis
Dr. Evan Manolis received his B.S. from University of Illinois at Chicago in 1987 and his M.D. in surgery from Southern Illinois University Medical School in 1991. He received extensive postgraduate training in general surgery internship and residency from the Medical College in Ohio.Β Dr. Manolis practices plastic surgery in Chicago and Orland Park, Illinois and has been in the profession for 16 years.
[edit] Strategic Alliances
[edit] Contact Information
Acrongenomics Inc. 14 Rue Kleberg, CH 1201, Geneva, Switzerland Tel: +41 22 716 5300 Fax: +41 22 716 5319 E-mail: info@acrongen.com Website: www.acrongen.com
